MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation

Published:2017-01-13 Issue:5 Volume:30 Page:682-697
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Yousef Einas M,Furrer Daniela,Laperriere David L,Tahir Muhammad R,Mader Sylvie,Diorio Caroline,Gaboury Louis A

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2016231.pdf

Reference74 articles.

1. American Cancer Society Cancer Facts and Figures. American Cancer Society: Atlanta, GA, USA, 2016.

2. Viale G . The current state of breast cancer classification. Ann Oncol 2012; 23: 207–210.

3. Caldarella A, Puliti D, Crocetti E et al, Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening. J Cancer Res Clin Oncol 2013; 139: 181–185.

4. Perou CM, Sorlie T, Eisen MB et al, Molecular portraits of human breast tumours. Nature 2000; 406: 747–752.

5. Sihto H, Lundin J, Lehtimaki T et al, Molecular subtypes of breast cancers detected in mammography screening and outside of screening. Clin Cancer Res 2008; 14: 4103–4110.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and Clinical Significance of the Proliferation Marker MCM7 in Breast Cancer;Pathobiology;2024-08-27

2. Carbon nanotubes conjugated with cisplatin activate different apoptosis signaling pathways in 2D and 3D-spheroid triple-negative breast cancer cell cultures: a comparative study;Archives of Toxicology;2024-05-13

3. FAM83D acts as an oncogene by regulating cell cycle progression via multiple pathways in synovial sarcoma: a potential novel downstream target oncogene of anlotinib;Discover Oncology;2024-03-21

4. RANKL inhibition reduces lesional cellularity and Gαs variant expression and enables osteogenic maturation in fibrous dysplasia;Bone Research;2024-02-20

5. Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas;International Journal of Medical Sciences;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3